Find comprehensive information on Artificial Aortic Valve, also known as Prosthetic Aortic Valve or Aortic Valve Replacement. This resource covers clinical documentation, medical coding, and healthcare aspects related to the diagnosis of an Artificial Aortic Valve. Learn about diagnosis codes, procedural terminology, and relevant clinical information for accurate and efficient medical record keeping. Explore essential details for healthcare professionals, including coding guidelines and best practices for documenting Artificial Aortic Valve conditions.
Also known as
Presence of artificial heart valve
Indicates the presence of an artificial heart valve, including aortic.
Aortic valve stenosis
Narrowing of the aortic valve, often leading to replacement.
Aortic (valve) insufficiency
Leakage of the aortic valve, a potential reason for replacement.
Rheumatic aortic stenosis
Aortic stenosis from rheumatic fever, may require valve replacement.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the artificial aortic valve currently in place?
When to use each related code
| Description |
|---|
| Artificial aortic valve |
| Aortic valve stenosis |
| Aortic valve regurgitation |
Coding lacks specificity regarding the type of artificial aortic valve (mechanical, bioprosthetic, etc.), impacting DRG assignment and reimbursement.
Missing documentation of the underlying cause for aortic valve replacement (e.g., stenosis, regurgitation) can lead to coding errors and compliance issues.
Incorrect coding of the specific aortic valve replacement procedure (TAVR, open surgery) can affect quality reporting and payment.
Q: What are the key postoperative management considerations for patients with a bioprosthetic aortic valve replacement?
A: Postoperative management of patients with a bioprosthetic aortic valve replacement focuses on hemodynamic stability, anticoagulation management, infection prophylaxis, and monitoring for complications. Early ambulation and pulmonary hygiene are crucial to prevent thromboembolic events and respiratory complications. Anticoagulation therapy, typically with warfarin for a limited duration (e.g., 3 months) is often prescribed depending on individual patient risk factors such as atrial fibrillation. Lifelong antibiotic prophylaxis for infective endocarditis is generally not recommended for bioprosthetic valves unless the patient has other risk factors like previous endocarditis or a prosthetic joint. Regular follow-up with echocardiography is essential to assess valve function and detect potential complications like paravalvular leak or structural valve deterioration. Explore how our comprehensive platform can assist in streamlining postoperative care pathways for optimal patient outcomes.
Q: How do I differentiate between structural valve deterioration (SVD) and prosthetic valve endocarditis (PVE) in a patient with a mechanical aortic valve replacement?
A: Differentiating between structural valve deterioration (SVD) and prosthetic valve endocarditis (PVE) in a patient with a mechanical aortic valve replacement can be challenging, as both can present with similar symptoms such as heart failure or new-onset murmur. SVD typically manifests as stenosis or regurgitation due to wear and tear or pannus formation, often observed through echocardiography showing changes in valve leaflet motion or increased transvalvular gradients. PVE, on the other hand, is an infection of the valve and surrounding tissue, potentially accompanied by fever, leukocytosis, and positive blood cultures. Transesophageal echocardiography (TEE) is often crucial for detecting vegetations or abscesses suggestive of PVE. Consider implementing a multidisciplinary approach involving cardiology, infectious disease, and cardiac surgery to accurately diagnose and manage these complex cases. Learn more about the latest diagnostic criteria for PVE and SVD to enhance your clinical decision-making.
Patient presents for follow-up evaluation of their artificial aortic valve. The patient's aortic valve replacement, a bioprosthetic valve or mechanical valve depending on previous documentation, was placed on [Date of surgery]. Current symptoms include [List current symptoms, e.g., dyspnea on exertion, chest pain, palpitations, or asymptomatic]. Physical examination reveals [Document heart rate, rhythm, presence or absence of murmurs, and other relevant cardiovascular findings]. Echocardiogram performed on [Date of echocardiogram] demonstrates [Specific findings, e.g., mean pressure gradient, valve function, presence or absence of paravalvular leak, left ventricular ejection fraction]. Patient's international normalized ratio (INR) is [INR value if applicable] and they are currently prescribed [Medications, e.g., warfarin, aspirin, antiplatelet therapy]. The patient's condition is assessed as stable, improved, or worsening depending on clinical presentation. Plan includes continued monitoring of valve function with repeat echocardiography in [Timeframe], optimization of anticoagulation therapy if applicable, and patient education regarding signs and symptoms of valve dysfunction. Discussion regarding potential complications, including thromboembolism, endocarditis, and structural valve deterioration, was reviewed with the patient. Follow-up appointment scheduled in [Timeframe]. Diagnoses include: Aortic valve prosthesis, status post aortic valve replacement.